Literature DB >> 12471913

Clinicopathological study of carcinoma of the breast in Benin City.

M N Okobia1, U Osime.   

Abstract

Morbidity and mortality from breast cancer have continued to be a source of concern to surgeons in many countries. Over a period of 10 years--January 1987 to December 1996--117 patients presented with carcinoma of the breast at the University of Benin Teaching Hospital in Benin City, Nigeria. The case files of 77 patients were available and were analysed retrospectively. There were 75 females and 2 males. Sixty seven per cent of the female patients had large and grossly advanced lesions. Most of them were multiparous and they practiced prolonged breastfeeding. Seventy eight per cent of the patients delayed for over 3 months before presenting to the hospital. The five-year survival was 8.7%. We conclude that carcinoma of the breast is common in this community and that most of the patients present late to the hospital.

Entities:  

Mesh:

Year:  2001        PMID: 12471913

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  16 in total

Review 1.  Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Elima Jedy-Agba; Valerie McCormack; Clement Adebamowo; Isabel Dos-Santos-Silva
Journal:  Lancet Glob Health       Date:  2016-12       Impact factor: 26.763

2.  The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a Nigerian semiurban teaching hospital: a single-center descriptive study.

Authors:  Olukayode Adeolu Arowolo; Andrew Akinbolaji Akinkuolie; Oladejo Olukayode Lawal; Olusegun Isaac Alatise; Abdulkadir Ayo Salako; Adewale Oluseye Adisa
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Intracystic papillary carcinoma of the breast in a 21-year old premenopausal Nigerian woman: a case report.

Authors:  Ivy N Umanah; Akpan S Okpongette
Journal:  Rare Tumors       Date:  2009-12-28

4.  ADVANCED, RECURRENT, INVASIVE CRIBIFORM CARCINOMA OF THE BREAST IN A 17-YEAR-OLD MALE: A CASE REPORT.

Authors:  M E Aghahowa; I K Salu; K N Ezike; O S Bassey; M U Umar; O A Etim; I A Okwudire-Ejeh
Journal:  J West Afr Coll Surg       Date:  2018 Oct-Dec

5.  A comparison of clinicopathological features and molecular markers in british and nigerian women with breast cancer.

Authors:  Isaac D Gukas; Anne C Girling; Barnabas M Mandong; Wendy Prime; Barbara A Jennings; Samuel J Leinster
Journal:  Clin Med Oncol       Date:  2008-04-24

6.  Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study.

Authors:  Michael N Okobia; Clareann H Bunker; Friday E Okonofua; Usifo Osime
Journal:  World J Surg Oncol       Date:  2006-02-21       Impact factor: 2.754

7.  Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city.

Authors:  Adenike O Akhigbe; Vivian O Omuemu
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

8.  Awareness and Practice of Breast Self-Examination among Market Women in Abakaliki, South East Nigeria.

Authors:  Nc Obaji; Ha Elom; Um Agwu; Cg Nwigwe; Po Ezeonu; Ouj Umeora
Journal:  Ann Med Health Sci Res       Date:  2013-01

9.  Knowledge, attitude and practices of women towards breast cancer in benin city, Nigeria.

Authors:  So Azubuike; So Okwuokei
Journal:  Ann Med Health Sci Res       Date:  2013-04

10.  Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study.

Authors:  Olukayode A Arowolo; Uchenna O Njiaju; Temidayo O Ogundiran; Oyewale Abidoye; Olukayode O Lawal; Millicent Obajimi; Adebayo V Adetiloye; Hae K Im; Akinbolaji A Akinkuolie; Abideen Oluwasola; Kayode Adelusola; Adesunkanmi A Kayode; Augustine E Agbakwuru; Helen Oduntan; Chinedum P Babalola; Gini Fleming; Olusola C Olopade; Adeyinka Gladys Falusi; Muheez A Durosinmi; Olufunmilayo I Olopade
Journal:  Breast J       Date:  2013-07-19       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.